Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis

review OA: closed CC0 ⤵ 121 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-08

This systematic review and meta-analysis found that antimüllerian hormone levels are significantly reduced in women with ovarian endometriomas compared to those without.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Anti-Mullerian Hormone Endometriosis Ovarian Cysts Ovarian Reserve Anti-Mullerian Hormone Biomarkers Biomarkers Endometriosis Endometriosis Endometriosis Female Humans Ovarian Cysts Ovarian Cysts Ovarian Cysts Ovarian Reserve Prospective Studies Randomized Controlled Trials as Topic Randomized Controlled Trials as Topic Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (65)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:31.300640+00:00
License: CC0 · commercial use OK